The results of the UK Familial Ovarian Cancer Screening Study (UK FOCSS), which is led by UCL and co-funded by The Eve Appeal alongside Cancer Research UK and the UK Department of Health have been published in leading science journal, Clinical Oncology.
They demonstrate that screening women at high risk of ovarian cancer every four months may reduce the likelihood of being diagnosed with advanced stage ovarian cancer.
The results of the UK FOCSS study are an exciting step forward for women who are at high-risk of developing ovarian cancer, and can give them peace of mind before making a major decision as to whether to go ahead with invasive surgery at that moment in time. At The Eve Appeal we know that medical research takes time to shift from the lab benches into a clinical setting and benefiting women – but it is hoped that these results will help us move that one step closer.
